← PTC THERAPEUTICS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $58.3m | $111.8m | $169.5m | $288.0m | $208.8m | $189.7m | $279.8m | $594.0m | $779.7m | $984.6m | |
| Prepaid Expense and Other Assets, Current | $4.7m | $6.7m | $9.2m | $17.9m | $39.5m | $54.7m | $105.7m | $150.5m | $44.1m | $67.3m | |
| Inventory, Net | $1.7m | $10.8m | $16.1m | $19.3m | $18.7m | $15.9m | $21.8m | $30.6m | $23.2m | $79.6m | |
| Assets, Current | $261.3m | $249.1m | $320.9m | $779.3m | $1.2b | $954.4m | $693.8m | $1.2b | $1.4b | $2.3b | |
| Property, Plant and Equipment, Net | $7.4m | $8.4m | $12.7m | $21.5m | $33.8m | $52.6m | $72.6m | $87.1m | $61.0m | $55.4m | |
| Goodwill | — | $0 | $82.3m | $82.3m | $82.3m | $82.3m | $82.3m | $82.3m | $82.3m | $82.3m | |
| Intangible Assets, Net (Excluding Goodwill) | — | $133.0m | $701.0m | $710.5m | $715.3m | $724.8m | $705.9m | $379.5m | $118.8m | $388.8m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $13.7m | $84.4m | $77.4m | $102.4m | $91.9m | $56.7m | $80.1m | |
| Additional Financial Items | |||||||||||
| Assets | $269.3m | $391.7m | $1.1b | $1.6b | $2.2b | $1.9b | $1.7b | $1.9b | $1.7b | $2.9b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $5.2m | $7.5m | $7.3m | $9.4m | $13.0m | $10.4m | $12.5m | |
| Accounts Payable, Current | $6.3m | $15.3m | $6.0m | $10.3m | $18.7m | $23.0m | $27.3m | $6.0m | $17.3m | $45.5m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $9.0m | $79.5m | $73.6m | $100.9m | $97.6m | $74.9m | $93.6m | |
| Deferred Revenue, Current | $0 | $3.9m | $3.7m | $8.2m | $4.2m | — | $1.4m | $801k | $5.5m | $2.0m | |
| Deferred Revenue, Noncurrent | $1.6m | $8.0m | $3.7m | $8.2m | $4.2m | — | $1.4m | $801k | $5.5m | $2.0m | |
| Long-term Debt, Current Maturities | — | $0 | $11.7m | $20.0m | $8.3m | $149.5m | — | — | — | $286.6m | |
| Long-term Debt, Excluding Current Maturities | $98.2m | $145.0m | $141.3m | $293.9m | $309.1m | $281.9m | $571.7m | $284.2m | $285.4m | $286.6m | |
| Liabilities, Current | $49.6m | $82.0m | $166.8m | $235.9m | $277.3m | $509.3m | $406.2m | $603.1m | $581.0m | $968.4m | |
| Deferred Income Tax Liabilities, Net | — | — | — | $130.9m | $136.7m | $137.1m | $102.8m | $55.9m | — | — | |
| Other Liabilities, Noncurrent | $335k | $243k | $58k | $9.2m | $1.4m | — | $2.6m | $141k | $21.4m | $13.7m | |
| Deferred Tax Liabilities, Net | — | — | $121.3m | $130.9m | $136.7m | $137.1m | $102.8m | $55.9m | — | — | |
| Liabilities | $149.8m | $235.2m | $768.5m | $1.0b | $1.7b | $1.9b | $2.1b | $2.7b | $2.8b | $3.1b | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $34k | $42k | $51k | $62k | $70k | $71k | $72k | $75k | $77k | $80k | |
| Additional Paid in Capital | $856.1m | $966.5m | $1.3b | $1.8b | $2.2b | $2.1b | $2.3b | $2.5b | $2.6b | $2.7b | |
| Retained Earnings (Accumulated Deficit) | ($735.1m) | ($814.1m) | ($938.9m) | ($1.2b) | ($1.6b) | ($2.1b) | ($2.7b) | ($3.3b) | ($3.6b) | ($3.0b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($1.5m) | $4.0m | $1.5m | ($10.6m) | ($61.0m) | ($24.3m) | $4.8m | ($1.3m) | ($25.9m) | $10.5m | |
| Stockholders' Equity Attributable to Parent | $119.6m | $156.4m | $350.7m | $594.3m | $482.0m | $1.4m | ($347.1m) | ($818.6m) | ($1.1b) | ($205.3m) | |
| Liabilities and Equity | $269.3m | $391.7m | $1.1b | $1.6b | $2.2b | $1.9b | $1.7b | $1.9b | $1.7b | $2.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.